PE/Cyanine7 anti-mouse CD4 Antibody

Pricing & Availability
Clone
GK1.5 (See other available formats)
Regulatory Status
RUO
Other Names
L3T4, T4
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
GK1dot5_PECy7_030206
C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE/Cyanine7 (filled histogram) or rat IgG2b, ? PE/Cyanine7 isotype control (open histogram).
  • GK1dot5_PECy7_030206
    C57BL/6 mouse splenocytes were stained with CD4 (clone GK1.5) PE/Cyanine7 (filled histogram) or rat IgG2b, ? PE/Cyanine7 isotype control (open histogram).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100421 25 µg 71€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100422 100 µg 172€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD4 is a 55 kD protein also known as L3T4 or T4. It is a member of the Ig superfamily, primarily expressed on most thymocytes, a subset of T cells, and weakly on macrophages and dendritic cells. It acts as a coreceptor with the TCR during T cell activation and thymic differentiation by binding MHC class II and associating with the protein tyrosin kinase, lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse CTL clone V4
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: blocking of CD4+ T cell activation1,4,11, thymocyte costimulation3, in vitro and in vivo depletion2,5-8, blocking of egg-sperm cell adhesion1,4, immunohistochemical staining of acetone-fixed frozen sections9,10, immunoprecipitation1,2, and spatial biology (IBEX)12,13. The GK1.5 antibody is able to block CD4 mediated cell adhesion and T cell activation. Binding of GK1.5 antibody to CD4 T cells can be blocked by RM4-5 antibody, but not RM4-4 antibody. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100442) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Dialynas DP, et al. 1983. J. Immunol. 131:2445. (Block, IP)
  2. Dialynas DP, et al. 1983. Immunol. Rev. 74:29. (IP, Deplete)
  3. Wu L, et al. 1991. J. Exp. Med. 174:1617. (Costim)
  4. Godfrey DI, et al. 1994. J. Immunol. 152:4783. (Block)
  5. Gavett SH, et al. 1994. Am. J. Respir. Cell. Mol. Biol. 10:587. (Deplete)
  6. Schuyler M, et al. 1994. Am. J. Respir. Crit. Care Med. 149:1286. (Deplete)
  7. Ghobrial RR, et al. 1989. Clin. Immunol. Immunopathol. 52:486. (Deplete)
  8. Israelski DM, et al. 1989. J. Immunol. 142:954. (Deplete)
  9. Zheng B, et al. 1996. J. Exp. Med. 184:1083. (IHC)
  10. Frei K, et al. 1997. J. Exp. Med. 185:2177. (IHC)
  11. Felix NJ, et al. 2007. Nat. Immunol. 8:388. (Block)
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  2. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  3. Perruzza L, et al. 2019. Sci Rep. 9:9315. PubMed
  4. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  5. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  6. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  7. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  8. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  9. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  10. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  11. Proietti M, et al. 2019. Nat Commun. 10:250. PubMed
  12. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  13. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  14. Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed
  15. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  16. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  17. Fernandes RA, et al. 2020. eLife. 9:e58463.. PubMed
  18. Diao L, et al. 2022. iScience. 25:105511. PubMed
  19. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  20. Fitzgerald AA, et al. 2021. J Immunother Cancer. 9:. PubMed
  21. Crespo ÂC, et al. 2020. Cell. 182(5):1125-1139. PubMed
  22. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  23. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  24. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  25. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  26. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  27. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  28. Kaufmann U et al. 2019. Cell metabolism. 29(5):1104-1118 . PubMed
  29. Matsuoka S, et al. 2019. Haematologica. 105:226. PubMed
  30. Rolla S, et al. 2010. J Immunol. 184:6124. PubMed
  31. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  32. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  33. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  34. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  35. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  36. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  37. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  38. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  39. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  40. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  41. An J, et al. 2022. iScience. 25:103570. PubMed
  42. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  43. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  44. Wang H, et al. 2019. Nat Commun. 10:1898. PubMed
  45. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  46. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  47. Cha SE, et al. 2021. Oncoimmunology. 10:1899469. PubMed
  48. Tuganbaev T, et al. 2020. Cell. 182(6):1441-1459.e21. PubMed
  49. Ohmichi Y, et al. 2011. J Exp Med . 208:1015. PubMed
  50. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  51. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  52. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  53. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  54. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  55. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  56. Momin N, et al. 2022. Nat Commun. 13:109. PubMed
  57. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  58. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  59. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  60. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  61. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  62. Lee P, et al. 2014. J Immunol. 192:178. PubMed
  63. Becher J, et al. 2018. Dev Cell. 47:592. PubMed
  64. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  65. Bullard BL, et al. 2022. NPJ Vaccines. 7:65. PubMed
  66. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  67. Faust HJ, et al. 2020. J Clin Invest. 130:5493. PubMed
  68. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  69. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  70. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  71. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  72. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  73. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  74. Dai R, et al. 2021. Front Immunol. 12:727046. PubMed
  75. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  76. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  77. XS R, et al. 2015. Diabetes. 64 90. PubMed
  78. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  79. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  80. Cui Z, et al. 2021. Cell Death Dis. 12:775. PubMed
  81. Kitajima Y, et al. 2022. Cells. 11:. PubMed
  82. Busse DC, et al. 2020. J Virol. 94:00:00. PubMed
  83. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  84. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  85. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  86. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  87. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  88. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  89. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  90. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  91. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  92. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  93. Wang W, et al. 2021. STAR Protocols. 2(3):100756. PubMed
  94. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  95. Draijer C, et al. 2018. Sci Rep. 8:5105. PubMed
  96. Isvoranu G, et al. 2019. Oncol Lett. 17:4197. PubMed
  97. Li C, et al. 2018. Cell. 174:285. PubMed
  98. Nakornpakdee Y, et al. 2018. Asian Pac J Allergy Immunol. 36:265. PubMed
  99. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  100. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  101. Sanders K, et al. 2015. Cancer Immunol Res. 3: 891-901. PubMed
  102. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  103. Kimura S, et al. 2020. Am J Transplant. 20:977. PubMed
  104. Kelley WJ, et al. 2022. JCI Insight. :. PubMed
  105. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  106. Prüss H, et al. 2017. Nat Neurosci. 10.1038/nn.4643. PubMed
  107. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  108. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  109. Ambrosino E, et al. 2006. Cancer Res . 66:7734. PubMed
  110. Nagamata S, et al. 2019. Sci Rep. 9:3911. PubMed
  111. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  112. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  113. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  114. Simula L, et al. 2022. Mol Oncol. 16:188. PubMed
  115. RL M, et al. 2015. Proc Natl Acad Sci U S A. 112:6506-6514. PubMed
  116. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  117. Lerbs T, et al. 2020. JCI Insight. 5:00. PubMed
  118. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  119. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  120. Miao Y et al. 2019. Cell. 177(5):1172-1186 . PubMed
  121. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  122. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  123. Yu Z, et al. 2021. Biomed Res Int. 2021:9958745. PubMed
  124. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  125. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  126. Groves HT, et al. 2020. MBio. 11:e03236-19. PubMed
RRID
AB_312706 (BioLegend Cat. No. 100421)
AB_312707 (BioLegend Cat. No. 100422)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

Related FAQs

I am unable to see expression of T cell markers such as CD3 and CD4 post activation.
TCR-CD3 complexes on the T-lymphocyte surface are rapidly downregulated upon activation with peptide-MHC complex, superantigen or cross-linking with anti-TCR or anti-CD3 antibodies. PMA/Ionomycin treatment has been shown to downregulate surface CD4 expression. Receptor downregulation is a common biological phenomenon and so make sure that your stimulation treatment is not causing it in your sample type.

Other Formats

View All CD4 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD4 GK1.5 FC
Biotin anti-mouse CD4 GK1.5 FC, IHC-F, ICC
FITC anti-mouse CD4 GK1.5 FC, IHC-F, ICC
PE anti-mouse CD4 GK1.5 FC
PE/Cyanine5 anti-mouse CD4 GK1.5 FC
Purified anti-mouse CD4 GK1.5 FC, IHC-F, ICC, IP, Costim, Block, Depletion
PE/Cyanine7 anti-mouse CD4 GK1.5 FC
APC/Cyanine7 anti-mouse CD4 GK1.5 FC
Alexa Fluor® 647 anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Alexa Fluor® 488 anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Pacific Blue™ anti-mouse CD4 GK1.5 FC
Alexa Fluor® 700 anti-mouse CD4 GK1.5 FC
PerCP anti-mouse CD4 GK1.5 FC
PerCP/Cyanine5.5 anti-mouse CD4 GK1.5 FC
Brilliant Violet 421™ anti-mouse CD4 GK1.5 FC, ICC, IHC-F
Ultra-LEAF™ Purified anti-mouse CD4 GK1.5 FC, Block, Costim, Depletion, IHC, IP
Alexa Fluor® 594 anti-mouse CD4 GK1.5 IHC-F, FC, ICC, SB
Brilliant Violet 711™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 510™ anti-mouse CD4 GK1.5 FC, IHC-F, ICC
Brilliant Violet 605™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 785™ anti-mouse CD4 GK1.5 FC
PE/Dazzle™ 594 anti-mouse CD4 GK1.5 FC
APC/Fire™ 750 anti-mouse CD4 GK1.5 FC
GoInVivo™ Purified anti-mouse CD4 GK1.5 FC
Brilliant Violet 750™ anti-mouse CD4 GK1.5 FC
Brilliant Violet 650™ anti-mouse CD4 GK1.5 FC
Spark Blue™ 550 anti-mouse CD4 GK1.5 FC
Spark NIR™ 685 anti-mouse CD4 GK1.5 FC
KIRAVIA Blue 520™ anti-mouse CD4 GK1.5 FC
PE/Fire™ 640 anti-mouse CD4 GK1.5 FC
APC/Fire™ 810 anti-mouse CD4 GK1.5 FC
PE/Fire™ 700 anti-mouse CD4 GK1.5 FC
Spark Violet™ 538 anti-mouse CD4 GK1.5 FC
Spark YG™ 593 anti-mouse CD4 GK1.5 FC
Spark Blue™ 574 anti-mouse CD4 Antibody GK1.5 FC
Spark UV™ 387 anti-mouse CD4 GK1.5 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD4

  • Biotin anti-mouse CD4

  • FITC anti-mouse CD4

  • PE anti-mouse CD4

  • PE/Cyanine5 anti-mouse CD4

  • Purified anti-mouse CD4

  • PE/Cyanine7 anti-mouse CD4

  • APC/Cyanine7 anti-mouse CD4

  • Alexa Fluor® 647 anti-mouse CD4

  • Alexa Fluor® 488 anti-mouse CD4

  • Pacific Blue™ anti-mouse CD4

  • Alexa Fluor® 700 anti-mouse CD4

  • PerCP anti-mouse CD4

  • PerCP/Cyanine5.5 anti-mouse CD4

  • Brilliant Violet 421™ anti-mouse CD4

  • Ultra-LEAF™ Purified anti-mouse CD4

  • Alexa Fluor® 594 anti-mouse CD4

  • Brilliant Violet 711™ anti-mouse CD4

  • Brilliant Violet 510™ anti-mouse CD4

  • Brilliant Violet 605™ anti-mouse CD4

  • Brilliant Violet 785™ anti-mouse CD4

  • PE/Dazzle™ 594 anti-mouse CD4

  • APC/Fire™ 750 anti-mouse CD4

  • GoInVivo™ Purified anti-mouse CD4

  • Brilliant Violet 750™ anti-mouse CD4

  • Brilliant Violet 650™ anti-mouse CD4

  • Spark Blue™ 550 anti-mouse CD4

  • Spark NIR™ 685 anti-mouse CD4

  • KIRAVIA Blue 520™ anti-mouse CD4

  • PE/Fire™ 640 anti-mouse CD4

  • APC/Fire™ 810 anti-mouse CD4

  • PE/Fire™ 700 anti-mouse CD4

  • Spark Violet™ 538 anti-mouse CD4

  • Spark YG™ 593 anti-mouse CD4

  • Spark Blue™ 574 anti-mouse CD4 Antibody

  • Spark UV™ 387 anti-mouse CD4

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account